- cafead Feb 20, 2023 at 12:52: PM
via Daiichi Sankyo is going back after Seagen in the latest bout of patent infringement accusations.
The Japanese pharma announced Friday that the US Patent and Trademark Office (PTO) has agreed to the company’s request to restart a post-grant review of a Seagen patent.
article source
The Japanese pharma announced Friday that the US Patent and Trademark Office (PTO) has agreed to the company’s request to restart a post-grant review of a Seagen patent.
article source